Abstract

ObjectiveSurgical treatment for patients who refuse blood transfusion due to religious beliefs is an important issue related to medical safety. Few reports have examined pulmonary surgery for these patients, and we analyzed clinical characteristics in such cases.MethodsTen Jehovah’s Witness (JW) patients with lung tumor resection who declined blood transfusion for religious reasons between December 2013 and February 2020 at the Fukushima Medical University Hospital were included. Median total intraoperative blood loss was 17.5 mL (range 5–150 mL). Fibrin glue was used intraoperatively for 8 patients. Final pathological examination revealed pulmonary adenocarcinoma in 9 cases and metastasis of bladder cancer in 1 case. In 8 patients with pulmonary adenocarcinoma examined for epidermal growth factor receptor (EGFR) gene mutation, 6 cases showed mutation. No patients had serious complications, but 1 patient displayed temporary anemia due to postoperative hemorrhagic gastrointestinal ulcer.Result and conclusionsOur findings confirm that pulmonary resection is feasible and safe for JW patients if performed by experienced medical staff. However, awareness of complications associated with perioperative bleeding is important. Each JW patient should be interviewed individually and every available perioperative option aimed at blood-sparing management, including use of blood coagulation factors and fibrinogen concentrates, should be carefully discussed and clarified. In this study, the EGFR gene mutation rate was higher than usual for cases of lung adenocarcinoma. Further studies are necessary to assess clinical features in JW patients with lung cancer.

Highlights

  • Given the risks of perioperative bleeding and the refusal of blood transfusion on religious grounds, surgery for Jehovah’s Witness (JW) patients always represents a clinical challenge and has generated various ethical and legal concerns

  • After a median follow-up of 23 months from resection in 9 patients with lung cancer, 3 patients experienced recurrence (p-stage IIIA, 2 patients; p-stage IB, 1 patient). All these recurrences occurred within the first year after operation and 1 of these patients died of lung cancer 6 months postoperatively

  • JWs refuse blood product transfusions based on their religious beliefs

Read more

Summary

Introduction

Given the risks of perioperative bleeding and the refusal of blood transfusion on religious grounds, surgery for Jehovah’s Witness (JW) patients always represents a clinical challenge and has generated various ethical and legal concerns. Some reports have described perioperative prevention of bleeding and anemia for JW patients, but indicators of strategies for malignant tumor surgery in JW patients have remained lacking. Some recent reports have described experiences with JW, such as case reports of esophageal cancer

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call